Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-interval oral polio vaccine schedules in newborns
ACTRN12612000276853Phase 4Recruiting
- Sponsor
- World Health Organization
- Start
- Mar 2012
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of monovalent oral polio vaccine type 1, trivalent oral poliovirus vaccine and bivalent oral poliovirus vaccine in poliomyelitis (4 arms), sponsored by World Health Organization. Started Mar 2012; status: recruiting.
02
Drugs
monovalent oral polio vaccine type 1trivalent oral poliovirus vaccinebivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ACTRN12612000276853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000276853.